Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1992
10/30/1992WO1992019621A1 Pcp receptor ligands and the use thereof
10/30/1992CA2109420A1 Pcp receptor ligands and the use thereof
10/30/1992CA2067307A1 Optimized tablet formulation
10/30/1992CA2066898A1 Pharmaceutical compounds
10/30/1992CA2062510A1 Process for the preparation of 4'-demethylepipodophyllotoxin gluoside 4'-phosphates
10/29/1992WO1992018639A1 Novel retro-alpha-retinol derivatives and uses of retro-alpha-retinol
10/29/1992WO1992018610A2 Compositions and methods for endothelial binding
10/29/1992WO1992018545A1 Novel heparin derivatives and process for the preparation thereof
10/29/1992WO1992018544A1 Sulfate polysaccharides, preparation method, pharmaceutical composition and utilization
10/29/1992WO1992018524A1 N-alkyl-tauroursodeoxycholic acids and their therapeutically active derivatives, a process for their preparation and pharmaceutical compositions containing them
10/29/1992WO1992018519A1 Novel cytarabine derivatives, their production and use
10/29/1992WO1992018512A1 Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
10/29/1992WO1992018511A1 Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
10/29/1992WO1992018508A1 New cephem compounds
10/29/1992WO1992018501A1 Thiazolidinedione derivatives, production and use thereof
10/29/1992WO1992018497A1 Novel difluorinated quinolones, their preparation method and pharmaceutical compositions containing same
10/29/1992WO1992018496A1 New thalidomide derivatives, method of manufacture and use thereof in medicaments
10/29/1992WO1992018493A1 Benzopyranones, methods of manufacture and use thereof
10/29/1992WO1992018492A1 Methods and compositions for isolating taxanes
10/29/1992WO1992018490A1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
10/29/1992WO1992018489A1 Arylmorpholine, preparation and use
10/29/1992WO1992018486A1 Improved process for the preparation of [1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
10/29/1992WO1992018485A1 Anti-cancer coumpounds
10/29/1992WO1992018482A1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
10/29/1992WO1992018478A1 Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract
10/29/1992WO1992018475A2 Substituted phenylazacycloalkanes as cns agents
10/29/1992WO1992018474A2 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
10/29/1992WO1992018469A1 Anti-cancer antracene derivatives
10/29/1992WO1992018465A1 Compounds for inhibition of protein methylation
10/29/1992WO1992018462A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
10/29/1992WO1992018461A1 Ethanolamine derivatives with anti-pollakiuria activity
10/29/1992WO1992018159A1 Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity
10/29/1992WO1992018147A1 Convertible microemulsion formulations
10/29/1992WO1992018136A1 Blood substitutes and organ preservative solutions
10/29/1992WO1992018134A1 Macrocyclic lactam prokinetic agents
10/29/1992WO1992018133A1 Method of treatment using steroid mouthwash
10/29/1992WO1992018132A1 Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
10/29/1992WO1992018131A1 Method for potentiating primary drugs in treating multidrug resistant cells
10/29/1992WO1992018126A1 Method of improving donor organ function and preventing reperfusion injury
10/29/1992WO1992018124A1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST
10/29/1992WO1992018121A1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion
10/29/1992WO1992018119A1 Composition and method for treating tumors
10/29/1992WO1992018118A1 Medicaments
10/29/1992WO1992018116A1 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
10/29/1992WO1992018115A1 Use of heterocyclic compounds for the treatment of inflammatory pain
10/29/1992WO1992018112A1 Method of preventing nmda receptor complex-mediated neuronal damage
10/29/1992WO1992018111A2 Pharmaceutical composition for the treatment of gastritis
10/29/1992WO1992018110A1 Process for conditioning of water-soluble substances
10/29/1992WO1992018092A2 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
10/29/1992WO1992018091A1 Antimicrobial oral compositions
10/29/1992WO1992018090A2 Antimicrobial oral compositions
10/29/1992WO1992018089A2 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells
10/29/1992WO1992018006A1 Method for treating acute alkali exposure with carbon dioxide
10/29/1992WO1992018005A1 Method of treating trichotillomania and onychophagia
10/29/1992WO1992018004A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs
10/29/1992WO1992015607A3 Phenyl amidines derivatives useful as platelet aggregation inhibitors
10/29/1992WO1992015601A3 Heteroanthracycline antitumor analogs
10/29/1992WO1992015298A3 Pyrazole derivatives for treatment of gastrointestinal ulcer disease
10/29/1992WO1992014743A3 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/29/1992WO1992013532A3 Naphthoquinone derivatives for the treatment of chronic inflammation
10/29/1992WO1992010193A3 Homo-prostaglandin derivatives as ocular hypotensives
10/29/1992WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method
10/29/1992DE4213005A1 Antikonzeption bei weiblichen primaten ohne beeinflussung des menstruellen zyklus Contraception in female primates without influencing the menstrual cycle
10/29/1992DE4200954A1 New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
10/29/1992DE4114397A1 (beta)-carbolin-3- hydroxyalkylcarbonsaeureestrderivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln (Beta) carboline-3- hydroxyalkylcarbonsaeureestrderivate, processes for their preparation and their use in medicaments
10/29/1992DE4113820A1 Verwendung von torasemid zur behandlung von hirnoedemen Use of torasemide for the treatment of cerebral edema
10/29/1992CA2108786A1 Compositions and methods for endothelial binding
10/29/1992CA2108363A1 Sulphated polysaccharides, process for their preparation, pharmaceutical composition and utilization
10/29/1992CA2108256A1 Anti-cancer compounds
10/29/1992CA2108255A1 Anti-cancer compounds
10/29/1992CA2108174A1 Benzopyranones, methods of manufacture and use thereof
10/29/1992CA2107891A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
10/29/1992CA2107790A1 Compounds for inhibition of protein methylation
10/29/1992CA2107115A1 Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract
10/29/1992CA2106673A1 Improved process for the preparation of [1s-(1r*,2s*,3r*)]-n-(4-morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
10/29/1992CA2102221A1 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
10/28/1992WO1992019619A1 β-CARBOLIN-3-HYDROXYALKYL CARBOXYLIC ACID ESTER DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN MEDICAMENTS
10/28/1992EP0511181A1 Saliva substitute
10/28/1992EP0511168A1 Indoline hydrochloride salts and process for their preparation
10/28/1992EP0511118A1 Use of lysine and or arginine pyrrolidone carboxylate as anti-oxydant agent in a cosmetic or pharmaceutical composition
10/28/1992EP0511075A1 Sulfated polysaccharides, process for their preparation, pharmaceutical composition and use thereof
10/28/1992EP0511073A1 Antiserotonines, their preparation and medicaments containing them
10/28/1992EP0511072A1 2-Aminopyrimidin-4-carboxamid derivatives, their preparation and their therapeutical use
10/28/1992EP0511031A1 3-Aryl-oxazolidinon derivatives, process for their preparation and their use in therapeutics
10/28/1992EP0511002A2 C-3 phosphine oxide substituted carbacephalosporins
10/28/1992EP0510948A1 N-Hydroxy ureae as 5-lipoxygenase inhibitors
10/28/1992EP0510947A1 N-Hydroxy (thio)ureas as 5-lipoxygenase inhibitors
10/28/1992EP0510904A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510903A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510837A2 Synergistic combinations in the treatment of anxiety
10/28/1992EP0510813A1 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
10/28/1992EP0510812A1 Angiotensin II antagonists incorporating a substituted thiophene or furan
10/28/1992EP0510748A1 Use of a methoxy alkanoic acid of indazole for the manufacture of a medicament for the treatment of autoimmune diseases
10/28/1992EP0510719A1 Benzimidazole derivatives substituted with a radical group and their use for inhibiting gastric acid secretion
10/28/1992EP0510687A2 Infusion preparation
10/28/1992EP0510562A1 Pyridazines
10/28/1992EP0510526A1 Use of sulfonamides as drug and new sulfonamides
10/28/1992EP0510489A1 Use of R(+)-3-amino-1-hydroxy-pyrrolidin-2-one for treating anxiety
10/28/1992EP0510473A1 Thienyl-nonatetraenoic acid derivatives with anti-rheumatic activity
10/28/1992EP0510404A1 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids